These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16848926)

  • 1. Marked decrease in the incidence and prevalence of hepatitis A in the Basque Country, Spain, 1986-2004.
    Cilla G; Pérez-Trallero E; Artieda J; Serrano-Bengoechea E; Montes M; Vicente D
    Epidemiol Infect; 2007 Apr; 135(3):402-8. PubMed ID: 16848926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the hepatitis A epidemiological transition in Brazil and Mexico.
    Van Effelterre T; Guignard A; Marano C; Rojas R; Jacobsen KH
    Hum Vaccin Immunother; 2017 Aug; 13(8):1942-1951. PubMed ID: 28481680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region.
    Itani T; Jacobsen KH; Nguyen T; Wiktor SZ
    Vaccine; 2014 Oct; 32(46):6067-74. PubMed ID: 25236586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing epidemiology of hepatitis A infection in Izmir, Turkey.
    Kurugol Z; Aslan A; Turkoglu E; Koturoglu G
    Vaccine; 2011 Aug; 29(37):6259-61. PubMed ID: 21763745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.
    Lazcano-Ponce E; Conde-Gonzalez C; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
    Hum Vaccin Immunother; 2013 Feb; 9(2):375-81. PubMed ID: 23291940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil.
    Vitral CL; Ospina FL; Artimos S; Melgaço JG; Cruz OG; de Paula VS; Luz SB; Freire M; Gaspar LP; Amado LA; Engstrom EM; Fortes CD; Souza TC; Dias MN; Gaspar AM; Souto FJ
    Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):652-8. PubMed ID: 22850956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact.
    Ayouni K; Naffeti B; Ben Aribi W; Bettaieb J; Hammami W; Ben Salah A; Ammar H; Ben Miled S; Triki H
    BMC Infect Dis; 2020 Aug; 20(1):627. PubMed ID: 32842988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia.
    Vitral CL; da Silva-Nunes M; Pinto MA; de Oliveira JM; Gaspar AM; Pereira RC; Ferreira MU
    BMC Infect Dis; 2014 Aug; 14():458. PubMed ID: 25149658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waning of anti-HAV immunity in Shijiazhuang prefecture, Hebei province, China: a comparison of seroprevalence between 1992 and 2011.
    Chen Y; Zhang XJ; Zhao YL; Zhang YH; Wang SM; Hao ZY; Zhang ZY; Ma JC; Fang Y; Wang XY
    Vaccine; 2014 Oct; 32(47):6227-32. PubMed ID: 25258099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sociodemographical aspects of seroprevalence of hepatitis A virus in the settlement of Cavunge, a semi-arid region of Bahia State].
    Almeida D; Tavares-Neto J; Queiroz-Andrade M; Dias C; Ribeiro T; Silva F; Silva-Araújo J; Tatsch F; Paraná R
    Rev Soc Bras Med Trop; 2006; 39(1):76-8. PubMed ID: 16501772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy.
    Sofian M; Aghakhani A; Farazi AA; Banifazl M; Etemadi G; Azad-Armaki S; Ziazarifi A; Abhari Z; Eslamifar A; Khadem-Sadegh A; Izadi N; Ramezani A
    Travel Med Infect Dis; 2010 May; 8(3):176-9. PubMed ID: 20541138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.
    Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH
    Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis A antibodies in Eastern Bolivia: a population-based study.
    C MA; J M RT; A CR; M BN; M DG; S L MR
    J Med Virol; 2013 Oct; 85(10):1692-7. PubMed ID: 23861034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Population study of seroprevalence of antibodies against hepatitis A virus in the Community of Madrid, 2008-2009].
    García-Comas L; Ordobás M; Sanz JC; Ramos B; Arce A; Barranco D
    Enferm Infecc Microbiol Clin; 2016 Jan; 34(1):33-8. PubMed ID: 25728853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seroepidemiologic study of hepatitis A in the community of Madrid during the year 2002].
    Junquera S; Mateos M; Lasa E; Chacón J; Baquero F
    Enferm Infecc Microbiol Clin; 2004 Oct; 22(8):448-51. PubMed ID: 15482685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis A immunity in the District of Aveiro (Portugal): an eleven-year surveillance study (2002-2012).
    Pereira S; Linhares I; Neves AF; Almeida A
    Viruses; 2014 Mar; 6(3):1336-45. PubMed ID: 24638206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.
    Zhu Y; Yuan Z; Zhao Q; Chen G; Xu B
    Epidemiol Infect; 2013 Mar; 141(3):556-62. PubMed ID: 22687628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea.
    Lee SH; Kim HS; Park KO; Park JW; Chun SY; Lim SJ; Cho HJ; Kim SJ; Park HW; Moon HK; Shin WG; Kim KH; Jang MK; Lee JH; Kim HY
    Korean J Hepatol; 2010 Dec; 16(4):362-8. PubMed ID: 21415579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.